Navigation Links
Circle Biologics® Introduces Innovation in Medical Devices
Date:7/26/2010

MINNEAPOLIS, July 26 /PRNewswire/ -- Circle Biologics®, Inc. has announced a technological break-through in regenerative medicine – its Autologous Platelet Concentrator Platform (APC™).  This innovative single device platform is the first of its kind to incorporate both autologous (patient derived) cell concentration and protein concentration in one point-of-care device.

The APC patented design (which has earned the US Food and Drug Administration's 510(k) marketing approval from its Office of Cellular, Tissue and Gene Therapies for creation of Platelet Rich Plasma and concentrated Platelet Poor Plasma) is a two-chamber, closed system that allows the user to perform two processing steps without the risk of contamination or waste, typically associated with transferring fluids between devices.

According to Matthew Kyle, president of Circle Biologics, this device will bring significant benefits to the surgical and healing processes associated with Cardiosurgery, Orthopedics, Cosmetic Surgery and Dental care.

"While this is not the first platelet-rich plasma device on the market, it is the first to incorporate both patient derived cell and protein concentration in one," says Kyle.  "It's a technological advancement in treating the entire medical procedure, giving improved solutions for patients and providers."

With its unique insights to medical care, Circle Biologics is standardizing the process of patient derived, patient point of care bio-fluid and cellular preparation across several therapies (i.e., platelet-rich plasma, stem cell, and tissue enrichment/generation). Additionally, the company has developed solutions that address the entire procedure—from procurement to processing to delivery or implantation—with a streamlined combination of devices that spare cells, reduce outside exposure, and protect the user and recipient.

About Circle Biologics

Circle Biologics, Inc.  develops, manufactures and markets patented devices for the regenerative medicine industry. The company is integrating cutting-edge biologic treatments with proven surgical techniques, resulting in seamless point-of-care solutions.  Circle Biologics focuses on bringing innovative solutions to market that address the entire medical procedure and improve biological fluid access, processing, handling and delivery.  The privately-held company is headquartered in Minneapolis, Minnesota.  www.circlebiologics.com


'/>"/>
SOURCE Circle Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Circle Medical Devices, Texcel Medical Merge to Form CIRTEC Medical Systems
2. DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes
3. PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S
4. Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver
5. Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
6. Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS
7. Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
8. Nonin Medical Introduces Latest Generation of Veterinary Handheld Pulse Oximeter for Global Distribution
9. PLUS Diagnostics Introduces Industrys First System to Eliminate Misidentification of Bone Marrow Samples
10. Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
11. Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... Little Rock, AR (PRWEB) , ... October 13, ... ... owned firm with locations throughout Arkansas that offers insurance and financial preparation services, ... to benefit the Rock City Rescue organization. , Rock City Rescue is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
Breaking Medicine News(10 mins):